Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - Taylor & Francis
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …
被引用次数：18 相关文章

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - ingentaconnect.com
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - diva-portal.org
Background: Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …
[HTML] nih.gov

[HTML][HTML] Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious Diseases …, 2021 - ncbi.nlm.nih.gov
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.

O Ljungquist, M Lundgren, E Iliachenko, F Månsson… - 2022 - cabidigitallibrary.org
Background: Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - portal.research.lu.se
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.

O Ljungquist, M Lundgren, E Iliachenko… - Infectious Diseases …, 2021 - europepmc.org
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …
[HTML] lu.se

[HTML][HTML] Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren, E Iliachenko… - Infectious …, 2022 - lup.lub.lu.se
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …

Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

O Ljungquist, M Lundgren… - Infectious diseases …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …
[PDF] scienceopen.com

[PDF][PDF] Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

M Landin-Olsson, C Wikén, E Rosendal, AK Överby… - scienceopen.com
Background: Immunosuppressed patients are particularly vulnerable to severe infection from
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged …